HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan.

Abstract
In vitro anti-dermatophyte, anti-Candida albicans and anti-Malassezia furfur activities of amorolfine hydrochloride (AMF), terbinafine hydrochloride (TBF), butenafine hydrochloride (BTF), neticonazole hydrochloride (NCZ) and ketoconazole (KCZ), all of which were introduced for the treatment of dermatomycoses in the 1990s in Japan, were compared. Although all of the test drugs are classified as an ergosterol biosynthesis inhibitor, the antifungal properties were found to be different. TBF and BTF exerted extremely potent antifungal activity against Trichophyton spp. but not against C. albicans and M. furfur, whilst KCZ and NCZ showed potent antifungal activity against C. albicans and M. furfur rather than Trichophyton spp. AMF exhibited potent antifungal activity against all of the fungal species tested. Fungicidal activities of these antifungal agents against T. rubrum were determined by using neutral red staining. The fungicidal potentialities correlated with those obtained in the in vitro susceptibility test as determined by MICs against dermatophytes. TBF, BTF and AMF exerted more potent fungicidal action than NCZ and KCZ.
AuthorsK Nimura, Y Niwano, S Ishiduka, R Fukumoto
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 18 Issue 2 Pg. 173-8 (Aug 2001) ISSN: 0924-8579 [Print] Netherlands
PMID11516941 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Infective Agents, Local
  • Antifungal Agents
  • Neutral Red
Topics
  • Administration, Topical
  • Anti-Infective Agents, Local (pharmacology)
  • Antifungal Agents (pharmacology)
  • Candida albicans (drug effects)
  • Dermatomycoses (microbiology)
  • Humans
  • Japan
  • Malassezia (drug effects)
  • Microbial Sensitivity Tests (methods)
  • Mitosporic Fungi (drug effects)
  • Neutral Red
  • Trichophyton (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: